Autoimmune hemolytic anemia and red blood cell autoantibodies

Erin Quist, Scott A Koepsell

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Autoimmune hemolytic anemia is a rare disorder caused by autoreactive red blood cell (RBC) antibodies that destroy RBCs. Although autoimmune hemolytic anemia is rare, RBC autoantibodies are encountered frequently and can complicate transfusion workups, impede RBC alloantibody identification, delay distribution of compatible units, have variable clinical significance that ranges from benign to life-threatening, and may signal an underlying disease or disorder. In this review, we discuss the common presenting features of RBC autoantibodies, laboratory findings, ancillary studies that help the pathologist investigate the clinical significance of autoantibodies, and how to provide appropriate patient care and consultation for clinical colleagues. Pathologists must be mindful of, and knowledgeable about, this entity because it not only allows for direct clinical management but also can afford an opportunity to preemptively treat an otherwise silent malignancy or disorder.

Original languageEnglish (US)
Pages (from-to)1455-1458
Number of pages4
JournalArchives of Pathology and Laboratory Medicine
Volume139
Issue number11
DOIs
StatePublished - Nov 2015

Fingerprint

Autoimmune Hemolytic Anemia
Autoantibodies
Erythrocytes
Isoantibodies
Patient Care
Referral and Consultation
Antibodies
Neoplasms
Pathologists

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Autoimmune hemolytic anemia and red blood cell autoantibodies. / Quist, Erin; Koepsell, Scott A.

In: Archives of Pathology and Laboratory Medicine, Vol. 139, No. 11, 11.2015, p. 1455-1458.

Research output: Contribution to journalReview article

@article{bed03ead83b842e5b870b3cd6aef58a8,
title = "Autoimmune hemolytic anemia and red blood cell autoantibodies",
abstract = "Autoimmune hemolytic anemia is a rare disorder caused by autoreactive red blood cell (RBC) antibodies that destroy RBCs. Although autoimmune hemolytic anemia is rare, RBC autoantibodies are encountered frequently and can complicate transfusion workups, impede RBC alloantibody identification, delay distribution of compatible units, have variable clinical significance that ranges from benign to life-threatening, and may signal an underlying disease or disorder. In this review, we discuss the common presenting features of RBC autoantibodies, laboratory findings, ancillary studies that help the pathologist investigate the clinical significance of autoantibodies, and how to provide appropriate patient care and consultation for clinical colleagues. Pathologists must be mindful of, and knowledgeable about, this entity because it not only allows for direct clinical management but also can afford an opportunity to preemptively treat an otherwise silent malignancy or disorder.",
author = "Erin Quist and Koepsell, {Scott A}",
year = "2015",
month = "11",
doi = "10.5858/arpa.2014-0337-RS",
language = "English (US)",
volume = "139",
pages = "1455--1458",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "11",

}

TY - JOUR

T1 - Autoimmune hemolytic anemia and red blood cell autoantibodies

AU - Quist, Erin

AU - Koepsell, Scott A

PY - 2015/11

Y1 - 2015/11

N2 - Autoimmune hemolytic anemia is a rare disorder caused by autoreactive red blood cell (RBC) antibodies that destroy RBCs. Although autoimmune hemolytic anemia is rare, RBC autoantibodies are encountered frequently and can complicate transfusion workups, impede RBC alloantibody identification, delay distribution of compatible units, have variable clinical significance that ranges from benign to life-threatening, and may signal an underlying disease or disorder. In this review, we discuss the common presenting features of RBC autoantibodies, laboratory findings, ancillary studies that help the pathologist investigate the clinical significance of autoantibodies, and how to provide appropriate patient care and consultation for clinical colleagues. Pathologists must be mindful of, and knowledgeable about, this entity because it not only allows for direct clinical management but also can afford an opportunity to preemptively treat an otherwise silent malignancy or disorder.

AB - Autoimmune hemolytic anemia is a rare disorder caused by autoreactive red blood cell (RBC) antibodies that destroy RBCs. Although autoimmune hemolytic anemia is rare, RBC autoantibodies are encountered frequently and can complicate transfusion workups, impede RBC alloantibody identification, delay distribution of compatible units, have variable clinical significance that ranges from benign to life-threatening, and may signal an underlying disease or disorder. In this review, we discuss the common presenting features of RBC autoantibodies, laboratory findings, ancillary studies that help the pathologist investigate the clinical significance of autoantibodies, and how to provide appropriate patient care and consultation for clinical colleagues. Pathologists must be mindful of, and knowledgeable about, this entity because it not only allows for direct clinical management but also can afford an opportunity to preemptively treat an otherwise silent malignancy or disorder.

UR - http://www.scopus.com/inward/record.url?scp=84945893761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945893761&partnerID=8YFLogxK

U2 - 10.5858/arpa.2014-0337-RS

DO - 10.5858/arpa.2014-0337-RS

M3 - Review article

C2 - 26516943

AN - SCOPUS:84945893761

VL - 139

SP - 1455

EP - 1458

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 11

ER -